Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-05-22
1993-03-02
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514866, A61K 31505
Patent
active
051909480
ABSTRACT:
Uridine is used to treat the peripheral complications of diabetes, such as neuropathy, retinopathy and vasculopathy, thanks to its characteristics of promotor of glycogen endocellular biosynthesis. 40 diabetic patients were treated for six months with uridine or with placebo in a double-blind clinical teat.
REFERENCES:
CA 77(3): 14390d, Serra, 1971.
Geiger et al., report presented at the meeting of the Federation of Amer. Societies for Experimental Biol. pp. 93-100, Apr. 1956.
Elrick et al., Metabolism, vol. XI, No. 1, pp. 46-55, Jan. 21, 1961.
De Luca Giovanna
Di Stazio Giovanni
Materazzi Mario
Politi Vincenzo
Jordan Kimberly R.
Polifarma S.p.A.
Waddell Frederick E.
LandOfFree
Use of uridine in the pharmacological treatment of the periphera does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of uridine in the pharmacological treatment of the periphera, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of uridine in the pharmacological treatment of the periphera will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-126751